UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 7, 2024
 
ACM Research, Inc.
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
001-38273
94-3290283
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)

42307 Osgood Road, Suite I
   
Fremont, California
  94539
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (510) 445-3700
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading symbol
 
Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share
 
ACMR
 
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934:              Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.02.
Results of Operations and Financial Condition.
 
On November 7, 2024, we issued a press release announcing financial results for the third quarter of 2024. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

The information contained in this Item 2.02, including the exhibit furnished hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.

Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
Exhibit
 
Description
     
 
Press Release of ACM Research, Inc. dated November 7, 2024
     
104
 
Cover Page Interactive Data File (embedded within the XBRL document)

2

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 

ACM RESEARCH, INC.

 

By:
/s/ Mark McKechnie


Mark McKechnie


Chief Financial Officer and Treasurer



Dated: November 7, 2024




3


Exhibit 99.1

 
ACM Research Reports Third Quarter 2024 Results
 
FREMONT, Calif., Nov 07, 2024 (Globe Newswire) – ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its third quarter ended September 30, 2024.

“I am pleased to report another strong quarter for ACM, with record revenue and shipments, good profitability, and positive cash flow from operations,” said ACM’s President and Chief Executive Officer, Dr. David Wang. “We believe our results demonstrate ACM’s role as an innovator, delivering world-class tools that drive value for our customers and strengthen our position in the global market. Tahoe is gaining momentum with multiple logic and memory customers in production. This tool now delivers the same advanced cleaning performance as single-wafer tools, and at the same time up to 75% reduction of sulfuric acid use. We also believe the unique approach of our new panel products – including the Ultra ECP ap-p Horizontal Plating tool, the Ultra C vac-p Flux Cleaning tool, and the Ultra C bev-p Bevel Etching Tool – position ACM to become a significant contributor to the global adoption of AI chip manufacturing.”
 
Dr. Wang continued, “Looking ahead, we anticipate continued growth of our business in mainland China through market share gains and new product ramps. We have begun initial operations at our Lingang facility, and we remain committed to support major customers in the US, Europe, and Southeast Asia. Our near-term outlook has improved, and as a result, we have raised our 2024 revenue outlook.”
 
   
Three Months Ended September 30,
 
   
GAAP
   
Non-GAAP(1)
 
   
2024
   
2023
   
2024
   
2023
 
   
(dollars in thousands, except EPS)
 
Revenue
 
$
203,976
   
$
168,569
   
$
203,976
   
$
168,569
 
Gross margin
   
51.4
%
   
52.5
%
   
51.6
%
   
52.9
%
Income from operations
 
$
44,184
   
$
33,173
   
$
56,065
   
$
43,754
 
Net income attributable to ACM Research, Inc.
 
$
30,904
   
$
25,679
   
$
42,372
   
$
37,579
 
Basic EPS
 
$
0.49
   
$
0.43
   
$
0.68
   
$
0.62
 
Diluted EPS
 
$
0.45
   
$
0.39
   
$
0.63
   
$
0.57
 
 
   
Nine Months Ended September 30,
 
   
GAAP
   
Non-GAAP(1)
 
   
2024
   
2023
   
2024
   
2023
 
   
(dollars in thousands, except EPS)
 
Revenue
 
$
558,647
   
$
387,402
   
$
558,647
   
$
387,402
 
Gross margin
   
50.3
%
   
50.9
%
   
50.6
%
   
51.1
%
Income from operations
 
$
107,009
   
$
72,465
   
$
147,801
   
$
87,131
 
Net income attributable to ACM Research, Inc.
 
$
72,547
   
$
59,649
   
$
114,490
   
$
78,743
 
Basic EPS
 
$
1.17
   
$
0.99
   
$
1.85
   
$
1.31
 
Diluted EPS
 
$
1.07
   
$
0.90
   
$
1.70
   
$
1.19
 
 
(1)
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments.


Outlook

ACM has raised its revenue guidance range for fiscal year 2024 to a range of $725 million to $745 million from the prior range of $695 million to $735 million. This expectation is based on ACM management’s current assessment of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other factors.
 
Operating Highlights and Recent Announcements
 
Shipments. Total shipments in the third quarter of 2024 were $261 million, up 23% from the third quarter of 2023. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
 
Major Performance Breakthrough for Flagship Ultra C Tahoe Cleaning Tool. The upgraded Ultra C Tahoe now achieves the performance of standalone single-wafer cleaning tools on low-to-medium temperature sulfuric peroxide mix (SPM) processes. The hybrid architecture delivers enhanced cleaning performance, high throughput, and process flexibility, with an up to 75% reduction in chemical consumption. The upgraded Ultra C Tahoe is now in production at several high-volume customer facilities in mainland China. Additional logic and memory customers are evaluating the tool, and we expect to deliver additional units through the end 2024.
 

Launched Ultra C bev-p Panel Bevel Etching Tool for Panel-Level Packaging Applications. The new tool is specifically designed for bevel etching and cleaning in copper-related processes and is capable of handling both the front and back side etching within a single system. This capability enhances process efficiency and product reliability.
 
Received Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center. ACM has received purchase orders for four wafer-level packaging tools, including two from a U.S.-based customer and two from a U.S.-based research and development (R&D) center. The four tools support a range of advanced packaging processes and are scheduled for delivery in the first half of 2025.
 
Completed Purchase of Commercial Facility in Oregon. On October 1, 2024, ACM completed the purchase of a 39,500 square foot facility, including a 5,200 square foot functional clean room. This facility is intended to augment ACM’s current Oregon facility and further expand ACM’s R&D and demonstration capability in the U.S. market.

Opening of R&D and Production Facility. On October 20, 2024, ACM Shanghai celebrated the official opening of its new R&D and production facility in Lingang, China.
 
Third Quarter 2024 Financial Summary
 
Unless otherwise noted, the following figures refer to the third quarter of 2024 and comparisons are with the third quarter of 2023.
 
Revenue was $204.0 million, up 21%, reflecting higher sales of single wafer cleaning, Tahoe and semi-critical cleaning equipment and ECP (front-end and packaging), furnace and other technologies, partly offset by lower sales of advanced packaging (excluding ECP), services & spares.
 
Gross margin was 51.4% versus 52.5%. Non-GAAP gross margin, which excludes stock-based compensation, was 51.6% versus 52.9%. Gross margin exceeded ACM’s long-term business model range of 40% to 45%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
 
- 2 -

Operating expenses were $60.7 million, an increase of 10%. Operating expenses as a percentage of revenue decreased to 29.7% from 32.8%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $49.2 million, up 8.5%. Non-GAAP operating expenses as a percentage of revenue decreased to 24.1% from 26.9%.
 
Operating income was $44.2 million, compared to $33.2 million. Operating margin was 21.7% compared to 19.7%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $56.1 million, compared to $43.8 million. Non-GAAP operating margin, which excludes stock-based compensation, was 27.5% compared to 26.0%.
 
Unrealized gain (loss) on short-term investments was $0.4 million, compared to an unrealized gain (loss) of $(1.3) million. Unrealized gain (loss) reflects the change in market value of the investments by ACM’s principal operating subsidiary, ACM Research (Shanghai), Inc. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
 
Income tax expense was $4.0 million, compared to $0.7 million.
 
Net income attributable to ACM Research, Inc. was $30.9 million, compared to $25.7 million.  Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $42.4 million, compared to $37.6 million.
 
Net income per diluted share attributable to ACM Research, Inc. was $0.45, compared to $0.39.  Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain (loss) on short-term investments, was $0.63, compared to $0.57.
 
Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits were $369.1 million at September 30, 2024, compared to $366.8 million at June 30, 2024.
 
Conference Call Details
 
A conference call to discuss results will be held on Thursday, November 7, 2024, at 8:00 a.m. Eastern Time (9:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.

Online Registration: https://register.vevent.com/register/BIcf4dbc584cf54892966d5353590ab648
 
Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.
 
A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.
 
Use of Non-GAAP Financial Measures
 
ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”
 
- 3 -

ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.
 
While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.
 
Forward-Looking Statements
 
Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
 
About ACM Research, Inc.
ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing, vertical furnace processes, Track and PECVD, which are critical to advanced semiconductor device manufacturing and wafer-level packaging. ACM is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit www.acmrcsh.com.
 
© ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.
 
- 4 -

For investor and media inquiries, please contact:
 
 
In the United States:
The Blueshirt Group
   
Steven C. Pelayo, CFA
   
(360)808-5154
   
steven@blueshirtgroup.co
     
 
In China:
The Blueshirt Group Asia
   
Gary Dvorchak, CFA
   
+86 (138) 1079-1480
   
gary@blueshirtgroup.co

- 5 -

ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets
 
   
September 30, 2024
   
December 31, 2023
 
   
(Unaudited)
       
   
(In thousands)
 
Assets
           
Current assets:
           
Cash and cash equivalents
 
$
333,472
   
$
182,090
 
Restricted cash
   
1,782
     
1,083
 
Short-term time deposits
   
20,304
     
80,524
 
Short-term investment
   
20,351
     
21,312
 
Accounts receivable, net
   
370,589
     
283,186
 
Other receivables
   
57,849
     
40,065
 
Inventories, net
   
628,720
     
545,395
 
Advances to related party
   
1,453
     
2,432
 
Prepaid expenses
   
10,794
     
20,023
 
Total current assets
   
1,445,314
     
1,176,110
 
Property, plant and equipment, net
   
250,099
     
201,848
 
Land use right, net
   
8,320
     
8,367
 
Operating lease right-of-use assets, net
   
5,680
     
7,026
 
Intangible assets, net
   
2,838
     
2,538
 
Long-term time deposits
   
13,517
     
40,818
 
Deferred tax assets
   
13,400
     
20,271
 
Long-term investments
   
33,655
     
27,880
 
Other long-term assets
   
21,352
     
6,050
 
Total assets
 
$
1,794,175
   
$
1,490,908
 
Liabilities and Equity
               
Current liabilities:
               
Short-term borrowings
 
$
33,795
   
$
31,335
 
Current portion of long-term borrowings
   
30,670
     
6,783
 
Related party accounts payable
   
15,392
     
11,407
 
Accounts payable
   
170,810
     
141,814
 
Advances from customers
   
215,678
     
181,368
 
Deferred revenue
   
10,138
     
3,687
 
Income taxes payable
   
6,796
     
6,401
 
FIN-48 payable
   
8,991
     
12,149
 
Other payables and accrued expenses
   
115,388
     
102,951
 
Current portion of operating lease liability
   
2,377
     
2,764
 
Total current liabilities
   
610,035
     
500,659
 
Long-term borrowings
   
106,069
     
53,952
 
Long-term operating lease liability
   
3,303
     
4,262
 
Other long-term liabilities
   
5,685
     
5,873
 
Total liabilities
   
725,092
     
564,746
 
Commitments and contingencies
               
Equity:
               
Stockholders’ equity:
               
Class A Common stock
   
6
     
6
 
Class B Common stock
   
1
     
1
 
Additional paid-in capital
   
669,540
     
629,845
 
Retained earnings
   
229,374
     
156,827
 
Statutory surplus reserve
   
30,060
     
30,060
 
Accumulated other comprehensive loss
   
(40,815
)
   
(49,349
)
Total ACM Research, Inc. stockholders’ equity
   
888,166
     
767,390
 
Non-controlling interests
   
180,917
     
158,772
 
Total equity
   
1,069,083
     
926,162
 
Total liabilities and equity
 
$
1,794,175
   
$
1,490,908
 

- 6 -

ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Income

   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2024
   
2023
   
2024
   
2023
 
   
(Unaudited)
 
   
( In thousands, except share and per share data)
 
Revenue
 
$
203,976
   
$
168,569
   
$
558,647
   
$
387,402
 
Cost of revenue
   
99,142
     
80,055
     
277,908
     
190,263
 
Gross profit
   
104,834
     
88,514
     
280,739
     
197,139
 
Operating expenses:
                               
Sales and marketing
   
15,759
     
16,803
     
47,067
     
37,579
 
Research and development
   
27,837
     
26,151
     
77,723
     
60,244
 
General and administrative
   
17,054
     
12,387
     
48,940
     
26,851
 
Total operating expenses
   
60,650
     
55,341
     
173,730
     
124,674
 
Income from operations
   
44,184
     
33,173
     
107,009
     
72,465
 
Interest income
   
2,967
     
2,152
     
7,122
     
6,283
 
Interest expense
   
(1,208
)
   
(640
)
   
(2,923
)
   
(1,984
)
Realized gain from sale of short-term investments
   
171
     
656
     
444
     
8,569
 
Unrealized gain (loss) on short-term investments
   
413
     
(1,319
)
   
(1,151
)
   
(4,428
)
Other income (expense), net
   
(5,164
)
   
(2,150
)
   
(727
)
   
156
 
Income (loss) from equity method investments
   
1,316
     
(160
)
   
101
     
3,728
 
Income before income taxes
   
42,679
     
31,712
     
109,875
     
84,789
 
Income tax expense
   
(4,007
)
   
(718
)
   
(17,712
)
   
(11,235
)
Net income
   
38,672
     
30,994
     
92,163
     
73,554
 
Less: Net income attributable to non-controlling interests
   
7,768
     
5,315
     
19,616
     
13,905
 
Net income attributable to ACM Research, Inc.
 
$
30,904
   
$
25,679
   
$
72,547
   
$
59,649
 
Comprehensive income (loss):
                               
Net income
   
38,672
     
30,994
     
92,163
     
73,554
 
Foreign currency translation adjustment, net of tax
   
17,089
     
4,015
     
10,376
     
(21,831
)
Comprehensive Income
   
55,761
     
35,009
     
102,539
     
51,723
 
Less: Comprehensive income attributable to non-controlling interests
   
10,842
     
7,768
     
21,458
     
11,882
 
Comprehensive income (loss) attributable to ACM Research, Inc.
 
$
44,919
   
$
27,241
   
$
81,081
   
$
39,841
 
                                 
Net income attributable to ACM Research, Inc. per common share:
                               
Basic
 
$
0.49
   
$
0.43
   
$
1.17
   
$
0.99
 
Diluted
 
$
0.45
   
$
0.39
   
$
1.07
   
$
0.90
 
                                 
Weighted average common shares outstanding used in computing per share amounts:
                               
Basic
   
62,500,903
     
60,219,218
     
62,017,257
     
59,953,144
 
Diluted
   
66,671,526
     
65,450,941
     
66,512,143
     
64,834,051
 

- 7 -

ACM RESEARCH, INC.
Total Revenue by Product Category and by Region
 
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2024
   
2023
   
2024
   
2023
 
   
(Unaudited)
 
   
($ in thousand)
 
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
 
$
160,985
   
$
132,417
   
$
423,676
   
$
281,559
 
ECP (front-end and packaging), furnace and other technologies
   
34,600
     
25,508
     
99,362
     
71,223
 
Advanced packaging (excluding ECP), services & spares
   
8,391
     
10,644
     
35,609
     
34,620
 
Total Revenue By Product Category
 
$
203,976
   
$
168,569
   
$
558,647
   
$
387,402
 
 
   
Three Months Ended
September 30,
   
Nine Months Ended
September 30,
 
   
2024
   
2023
   
2024
   
2023
 
Mainland China
 
$
203,672
   
$
168,302
   
$
552,642
   
$
375,528
 
Other Regions
   
304
     
267
     
6,005
     
11,874
 
Total Revenue By Region
 
$
203,976
   
$
168,569
   
$
558,647
   
$
387,402
 

- 8 -

ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
 
As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:
 
   
Three Months Ended September 30,
 
   
2024
   
2023
 
   
Actual
(GAAP)
   
SBC
   
Other non-
operating adjustments
   
Adjusted
(Non-GAAP)
   
Actual
(GAAP)
   
SBC
   
Other non-
operating adjustments
   
Adjusted
(Non-GAAP)
 
   
(In thousands)
 
Revenue
 
$
203,976
   
$
-
   
$
-
   
$
203,976
   
$
168,569
   
$
-
   
$
-
   
$
168,569
 
Cost of revenue
   
(99,142
)
   
(447
)
   
-
     
(98,695
)
   
(80,055
)
   
(588
)
   
-
     
(79,467
)
Gross profit
   
104,834
     
(447
)
   
-
     
105,281
     
88,514
     
(588
)
   
-
     
89,102
 
Gross margin
   
51.4
%
   
0.2
%
   
-
     
51.6
%
   
52.5
%
   
0.3
%
   
-
     
52.9
%
Operating expenses:
                                                               
Sales and marketing
   
(15,759
)
   
(2,594
)
   
-
     
(13,165
)
   
(16,803
)
   
(2,543
)
   
-
     
(14,260
)
Research and development
   
(27,837
)
   
(3,373
)
   
-
     
(24,464
)
   
(26,151
)
   
(3,421
)
   
-
     
(22,730
)
General and administrative
   
(17,054
)
   
(5,467
)
   
-
     
(11,587
)
   
(12,387
)
   
(4,029
)
   
-
     
(8,358
)
Total operating expenses
   
(60,650
)
   
(11,434
)
   
-
     
(49,216
)
   
(55,341
)
   
(9,993
)
   
-
     
(45,348
)
Income (loss) from operations
 
$
44,184
   
$
(11,881
)
 
$
-
   
$
56,065
   
$
33,173
   
$
(10,581
)
 
$
-
   
$
43,754
 
Unrealized gain (loss) on short-term investments
   
413
     
-
     
413
     
-
     
(1,319
)
   
-
     
(1,319
)
   
-
 
Net income (loss) attributable to ACM Research, Inc.
 
$
30,904
   
$
(11,881
)
 
$
413
   
$
42,372
   
$
25,679
   
$
(10,581
)
 
$
(1,319
)
 
$
37,579
 
Basic EPS
 
$
0.49
                   
$
0.68
   
$
0.43
                   
$
0.62
 
Diluted EPS
 
$
0.45
                   
$
0.63
   
$
0.39
                   
$
0.57
 
 
- 9 -

   
Nine Months Ended September 30,
 
   
2024
   
2023
 
   
Actual
(GAAP)
   
SBC
   
Other non-
operating adjustments
   
Adjusted
(Non-GAAP)
   
Actual
(GAAP)
   
SBC
   
Other non-
operating adjustments
   
Adjusted
(Non-GAAP)
 
   
(In thousands)
 
Revenue
 
$
558,647
   
$
-
   
$
-
   
$
558,647
   
$
387,402
   
$
-
   
$
-
   
$
387,402
 
Cost of revenue
   
(277,908
)
   
(2,020
)
   
-
     
(275,888
)
   
(190,263
)
   
(838
)
   
-
     
(189,425
)
Gross profit
   
280,739
     
(2,020
)
   
-
     
282,759
     
197,139
     
(838
)
   
-
     
197,977
 
Gross margin
   
50.3
%
   
0.4
%
   
-
     
50.6
%
   
50.9
%
   
0.2
%
   
-
     
51.1
%
Operating expenses:
                                                               
Sales and marketing
   
(47,067
)
   
(8,645
)
   
-
     
(38,422
)
   
(37,579
)
   
(3,405
)
   
-
     
(34,174
)
Research and development
   
(77,723
)
   
(12,082
)
   
-
     
(65,641
)
   
(60,244
)
   
(4,831
)
   
-
     
(55,413
)
General and administrative
   
(48,940
)
   
(18,045
)
   
-
     
(30,895
)
   
(26,851
)
   
(5,592
)
   
-
     
(21,259
)
Total operating expenses
   
(173,730
)
   
(38,772
)
   
-
     
(134,958
)
   
(124,674
)
   
(13,828
)
   
-
     
(110,846
)
Income (loss) from operations
 
$
107,009
   
$
(40,792
)
 
$
-
   
$
147,801
   
$
72,465
   
$
(14,666
)
 
$
-
   
$
87,131
 
Unrealized gain (loss) on short-term investments
   
(1,151
)
   
-
     
(1,151
)
   
-
     
(4,428
)
   
-
     
(4,428
)
   
-
 
Net income (loss) attributable to ACM Research, Inc.
 
$
72,547
   
$
(40,792
)
 
$
(1,151
)
 
$
114,490
   
$
59,649
   
$
(14,666
)
 
$
(4,428
)
 
$
78,743
 
Basic EPS
 
$
1.17
                   
$
1.85
   
$
0.99
                   
$
1.31
 
Diluted EPS
 
$
1.07
                   
$
1.70
   
$
0.90
                   
$
1.19
 


- 10 -

v3.24.3
Document and Entity Information
Nov. 07, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 07, 2024
Entity File Number 001-38273
Entity Registrant Name ACM Research, Inc.
Entity Central Index Key 0001680062
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 94-3290283
Entity Address, Address Line One 42307 Osgood Road
Entity Address, Address Line Two Suite I
Entity Address, City or Town Fremont
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94539
City Area Code 510
Local Phone Number 445-3700
Title of 12(b) Security Class A Common Stock, par value $0.0001 per share
Trading Symbol ACMR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false

ACM Research (NASDAQ:ACMR)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 ACM Research 차트를 더 보려면 여기를 클릭.
ACM Research (NASDAQ:ACMR)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 ACM Research 차트를 더 보려면 여기를 클릭.